Vishal Mega Mart, Sai Life Sciences, Park Medi: Expert's Big Call After Lock-In Expiry

More than ₹20,000 crore worth of shares across Park Medi World, Vishal Mega Mart, Nephrocare Health Services and Sai Life Sciences have become eligible for trading as lock-in periods expire. But does that mean investors should rush to sell? Market expert Sudip Bandyopadhyay believes the answer is a clear no. He says retail investors should not base their exit decisions on lock-in expiry events, as institutional investors often operate under different timelines and mandates. In fact, any sharp correction caused by supply pressure could create a buying opportunity. The expert remains positive on Vishal Mega Mart, Park Medi World and Sai Life Sciences, citing strong business fundamentals and sector tailwinds. Watch this detailed discussion on how investors should navigate the latest lock-in expiry event.